| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50122-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52664-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35150-10ug | |||
| Carrier-Free | NBP2-35150-1mg | |||
| Carrier-Free | NBP2-35150-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52639-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34902-1mg | |||
| Carrier-Free | NBP2-34902-100ug | |||
| Carrier-Free | NBP2-34902-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50431-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50128-0.025ml | |||
![Western Blot: Troponin I Type 3 (cardiac) [p Ser43] Antibody [NBP2-29515] - Western blot of mouse heart lysate showing specific immunolabeling of the ~25k cTnI protein phosphorylated at Ser43 (control). Phosphospecificity is shown in the second lane. The blot is identical to the control except that the lysate was incubated in lambda-Ptase (1400 units for 30 min). The immunolabeling is greatly decreased by treatment with lambda-Ptase.](http://images.novusbio.com/fullsize/Troponin-I-Type-3-cardiac-p-Ser43-Antibody-Western-Blot-NBP2-29515-img0001.jpg "Western Blot: Troponin I Type 3 (cardiac) [p Ser43] Antibody [NBP2-29515] - Western blot of mouse heart lysate showing specific immunolabeling of the ~25k cTnI protein phosphorylated at Ser43 (control). Phosphospecificity is shown in the second lane. The blot is identical to the control except that the lysate was incubated in lambda-Ptase (1400 units for 30 min). The immunolabeling is greatly decreased by treatment with lambda-Ptase.")
![Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Cat phenotyping. The whole blood cells from the cat were washed and incubated at 4degree with the antibody. It helped characterize Tcell population in the species.This image was submitted via customer review. Image from the Allophycocyanin version of this antibody.](http://images.novusbio.com/fullsize/CD4-Antibody-3-4F4-Flow-Cytometry-NBP1-28258-img0004.jpg "Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Cat phenotyping. The whole blood cells from the cat were washed and incubated at 4degree with the antibody. It helped characterize Tcell population in the species.This image was submitted via customer review. Image from the Allophycocyanin version of this antibody.")
![Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Analysis using the FITC conjugate of NBP1-28258. Multiple staining of peripheral lymphocytes.](http://images.novusbio.com/fullsize/CD4-Antibody-3-4F4-Flow-Cytometry-NBP1-28258-img0002.jpg)
![Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Analysis using the FITC conjugate of NBP1-28258. Double staining of 1 ug/10^6 Peripheral blood mononuclear cells from a healthy domestic cat with mouse anti-feline CD4-FITC and mouse anti-feline CD8-R-PE.](http://images.novusbio.com/fullsize/CD4-Antibody-3-4F4-Flow-Cytometry-NBP1-28258-img0003.jpg)
![Flow Cytometry: CD19 Antibody (4G7) - Chimeric [NBP2-52664] - Flow-cytometry using anti-CD19 antibody 4G7. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of 4G7 (NBP2-52664, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD19-Antibody-4G7-Chimeric-Flow-Cytometry-NBP2-52664-img0001.jpg "Flow Cytometry: CD19 Antibody (4G7) - Chimeric [NBP2-52664] - Flow-cytometry using anti-CD19 antibody 4G7. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of 4G7 (NBP2-52664, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![SDS-Page: Recombinant Mouse SCF/c-kit Ligand Protein [NBP2-35150] - SDS-PAGE of NBP2-35150](http://images.novusbio.com/fullsize/Mouse-SCF-c-kit-Ligand-Protein-SDS-Page-NBP2-35150-img0001.jpg "SDS-Page: Recombinant Mouse SCF/c-kit Ligand Protein [NBP2-35150] - SDS-PAGE of NBP2-35150")
![Immunohistochemistry-Paraffin: ErbB2/Her2 Antibody (4D5-8 (trastuzumab)) - Chimeric [NBP2-52639] - Immunohistochemical Anti-erbB-2 (Her-2/neu) staining of paraffin embedded human breast tissue using the rabbit-chimeric version of 4D5-8 (trastuzumab) (NBP2-52639). Primary antibody incubation with NBP2-52639 was carried out at 4 ug/ml for 30 minutes. Samples were then incubated with an anti-rabbit IgG HRP secondary antibody for 20 mins followed by DAB (3,3'-diaminobenzidine), and counter-staining with haemotoxylin. Weak membrane staining exclusively of ductal epithelial cells may be observed. Recommended concentration, 4-6 ug/ml.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-4D5-8-trastuzumab-Chimeric-Immunohistochemistry-Paraffin-NBP2-52639-img0001.jpg "Immunohistochemistry-Paraffin: ErbB2/Her2 Antibody (4D5-8 (trastuzumab)) - Chimeric [NBP2-52639] - Immunohistochemical Anti-erbB-2 (Her-2/neu) staining of paraffin embedded human breast tissue using the rabbit-chimeric version of 4D5-8 (trastuzumab) (NBP2-52639). Primary antibody incubation with NBP2-52639 was carried out at 4 ug/ml for 30 minutes. Samples were then incubated with an anti-rabbit IgG HRP secondary antibody for 20 mins followed by DAB (3,3'-diaminobenzidine), and counter-staining with haemotoxylin. Weak membrane staining exclusively of ductal epithelial cells may be observed. Recommended concentration, 4-6 ug/ml.")
![SDS-Page: Human IL-7 Protein [NBP2-34902] - MW= Approximately 17 kDa](http://images.novusbio.com/fullsize/Human-IL-7-Protein-SDS-Page-NBP2-34902-img0001.jpg "SDS-Page: Human IL-7 Protein [NBP2-34902] - MW= Approximately 17 kDa")
![Western Blot: Cyclin D2 Antibody (OTI5A6) - Azide and BSA Free [NBP2-70344] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Cyclin D2.](http://images.novusbio.com/fullsize/Cyclin-D2-Antibody-OTI5A6-Azide-and-BSA-Free-Western-Blot-NBP2-70344-img0001.jpg "Western Blot: Cyclin D2 Antibody (OTI5A6) - Azide and BSA Free [NBP2-70344] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Cyclin D2.")
![Western Blot: TFB1M Antibody (OTI6G4) - Azide and BSA Free [NBP2-74490] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TFB1M.](http://images.novusbio.com/fullsize/TFB1M-Antibody-OTI6G4-Azide-and-BSA-Free-Western-Blot-NBP2-74490-img0001.jpg "Western Blot: TFB1M Antibody (OTI6G4) - Azide and BSA Free [NBP2-74490] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TFB1M.")
![Western Blot: VRK1 Antibody (OTI2C9) - Azide and BSA Free [NBP2-74855] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VRK1.](http://images.novusbio.com/fullsize/VRK1-Antibody-OTI2C9-Azide-and-BSA-Free-Western-Blot-NBP2-74855-img0001.jpg "Western Blot: VRK1 Antibody (OTI2C9) - Azide and BSA Free [NBP2-74855] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VRK1.")